Methyl (5-bromopyridin-2-yl)carbamate

Catalog No. :
ACLVET835
CAS No. :
207922-56-3
Molecular Formula :
C7H7BrN2O2
Molecular Weight :
231.05

IUPAC Name:methyl (5-bromopyridin-2-yl)carbamate

Methyl (5-bromopyridin-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$111.00Login to see priceIn stockInquiry
5g97%$341.00Login to see priceIn stockInquiry
10g97%$680.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (5-bromopyridin-2-yl)carbamate
IUPAC Namemethyl (5-bromopyridin-2-yl)carbamate
MDL No.MFCD00739213
Molecular FormulaC7H7BrN2O2
Molecular Weight231.05
SMILESO=C(OC)NC1=NC=C(Br)C=C1
InChI KeyXYBRWUNZRUBCGY-UHFFFAOYSA-N
Synonym207922-56-3 | methyl (5-bromopyridin-2-yl)carbamate | 5-BROMO-2-(METHOXYCARBONYLAMINO)PYRIDINE | methyl N-(5-bromopyridin-2-yl)carbamate | TimTec1_005418 | (5-Bromo-pyridin-2-yl)-carbamic acid methyl ester | SCHEMBL5689000 | CHEMBL4889390 | DTXSID70355079 | HMS1549G06 | MFCD
CAS No.207922-56-3
PubChem CID790797

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACLVET835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVET835 route product structure diagram
    ACLVET835207922-56-3 In Stock
Inquiry

2. ACLVET835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVET835 route product structure diagram
    ACLVET835207922-56-3 In Stock
Inquiry

Comments (0)